PsygaBio Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

PsygaBio General Information

Description

Operator of a drug discovery company intended to develop therapeutics derived from natural compounds. The company uses a proprietary analytical platform, data-driven approach, unique know how and clinical trial framework that supports active compound identification and development, from mushroom cultivation and extraction through clinically approved formulations, enabling healthcare professionals to treat patients efficiently.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • P.O.B 3150
  • 5 Tarshish Street
  • Caesarea 3079822
  • Israel
+972
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • P.O.B 3150
  • 5 Tarshish Street
  • Caesarea 3079822
  • Israel
+972

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PsygaBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 30-Jun-2026 Completed Generating Revenue
2. Early Stage VC 09-Apr-2024 Completed Generating Revenue
1. Early Stage VC 08-Jun-2021 Completed Generating Revenue
To view PsygaBio’s complete valuation and funding history, request access »

PsygaBio Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
NFX Venture Capital Minority
TAO Synergies Corporation Minority
To view PsygaBio’s complete investors history, request access »

PsygaBio FAQs

  • When was PsygaBio founded?

    PsygaBio was founded in 2021.

  • Where is PsygaBio headquartered?

    PsygaBio is headquartered in Caesarea, Israel.

  • What industry is PsygaBio in?

    PsygaBio’s primary industry is Drug Discovery.

  • Is PsygaBio a private or public company?

    PsygaBio is a Private company.

  • What is PsygaBio’s current revenue?

    The current revenue for PsygaBio is .

  • Who are PsygaBio’s investors?

    NFX and TAO Synergies have invested in PsygaBio.

  • When was PsygaBio acquired?

    PsygaBio was acquired on 30-Jun-2026.

  • Who acquired PsygaBio?

    PsygaBio was acquired by Xtl Biopharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process